| Hepatocellular Carcinoma |
1 |
1 |
| Cancer |
0 |
0.77 |
| Biologic Therapy |
0 |
0.62 |
| Liver |
0 |
0.48 |
| Toxicology |
0 |
0.35 |
| Quality of Life |
0 |
0.29 |
| Radiation Therapy |
0 |
0.29 |
| Ablation |
0 |
0.19 |
| Clinical Research |
0 |
0.19 |
| Immunotherapy |
0 |
0.19 |
| Surgery |
0 |
0.19 |
| Healthcare and Medical Technology |
0 |
0.14 |
| Tyrosine Kinase Inhibitor |
0 |
0.14 |
| Hepatitis B Virus |
0 |
0.12 |
| Angiogenesis Inhibitors |
0 |
0.1 |
| California |
0 |
0.1 |
| Hemorrhage |
0 |
0.1 |
| Hepatitis |
0 |
0.1 |
| Hepatitis A |
0 |
0.1 |
| Hepatitis C Virus |
0 |
0.1 |
| Humanized Monoclonal Antibody |
0 |
0.1 |
| Tyrosine Kinase |
0 |
0.1 |